Abbott Japan LLC
Abbott launches FreeStyle Libre(R) 2, a continuous glucose meter for diabetes management that can measure glucose levels in real time every minute and has a selectable alert function
……
The FreeStyle Libre(R) 2 can measure glucose levels in real time every minute and has added selectable alerts to help detect
hypoglycemia/hyperglycemia.
By being easy to use and visualizing “blood sugar trends” anytime and anywhere, it encourages behavioral changes in people with diabetes and contributes to better blood sugar management.
It has stable measurement accuracy over 14 days, and these functions support people with diabetes to live a better life.
March 28, 2024 – Abbott Japan LLC (Headquarters: Minato-ku, Tokyo; Representative Executive Officer and President: Hideyuki Takechi; hereinafter referred to as “Abbott”) has launched a long-term care product that can be used by people living with diabetes to self-manage their diabetes. We are pleased to announce the release of the new glucose meter “FreeStyle Libre(R) 2″. The FreeStyle Libre 2 is the next generation of the FreeStyle Libre, launched by Abbott in 2017, and provides real-time glucose readings every minute and features selectable alerts. In Japan, self-monitoring of blood sugar (SMBG) is widely used to manage diabetes, but since it requires finger prick blood sampling, it is necessary to secure an appropriate location and time. In addition, although SMBG can pinpoint the blood sugar level at the time of measurement, it has a problem in that it is limited in detecting 24-hour blood sugar fluctuations, including during the night, such as blood sugar spikes and hypoglycemia/hyperglycemia. there is. The new FreeStyle Libre 2 can measure glucose levels in real time every minute and has added selectable alerts to help detect hypo/hyperglycemia. In addition, FreeStyle Libre 2 is easy to use, and by visualizing blood sugar trends anytime and anywhere, it encourages behavioral changes in patients and contributes to better blood sugar management. The FreeStyle Libre 2 has stable measurement accuracy over 14 days, and these functions help patients lead a better life. Dr. Rimei Nishimura, chief professor of the Department of Diabetes, Metabolism, and Endocrinology at the Jikei University School of Medicine, said: “People with diabetes often do not see any improvement in indicators such as HbA1c even if they try to improve their lifestyle after being diagnosed with diabetes. Many people find it difficult to stay motivated to continue their treatment, but FreeStyle Libre 2 provides real-time glucose readings measured every minute to help improve your glucose profile and give you more selective alerts. In people with diabetes, continuous monitoring of your 24-hour glucose profile can help you adjust your lifestyle and It is expected that a deeper understanding of the relationship between changes in glucose levels, etc. will lead to better management of diabetes and a reduction in the risk of diabetic complications.Furthermore, FreeStyle Libre-related products are aimed at people living with diabetes in Japan. There is a wealth of clinical trials and evidence, and we believe that FreeStyle Libre 2 can be useful in this respect as well.” Hisao Matsuka, general manager of Abbott Japan G.K. Diabetes Care Division, said: It is stated as follows. “Abbott views Japan as an important market, and since the launch of FreeStyle Libre in 2017, we have listened to the requests and opinions of healthcare
professionals and users regarding our products and strived to improve new products and services. Some people have many concerns, such as how their blood sugar is changing and whether they will suddenly suffer from hypoglycemia.FreeStyle Libre 2 shows the status of blood sugar in more detail and relieves these concerns. We will continue to work with healthcare professionals to contribute to richer, healthier lives for people living with diabetes.” We have opened an official LINE account for the support program “FreeStyle Libre Care”. Users can easily register for FreeStyle Librecare from LINE. By registering, you will be able to watch videos on how to properly use FreeStyle Libre and receive regular information on how to better manage your blood sugar. It is expected that the daily burden of FreeStyle Libre 2 users and medical professionals involved in medical treatment will be reduced, leading to continued treatment and, ultimately, better blood sugar management.
Abbott will continue to contribute to richer, healthier lives for people living with diabetes through the provision of products and support.
[Image: https://prtimes.jp/i/34735/29/resize/d34735-29-803af62b5e93495deda3-0.png&s3=34735-29-8a70f5c1da1b1fa5f71355045f5aa621-834×914.png ]
FreeStyle Libre 2 sensor, FreeStyle LibreLink app screen
About FreeStyle Libre
Abbott’s FreeStyle Libre is the world’s leading device using continuous glucose measurement technology [1], used by more than 5.5 million people in more than 60 countries [2]. FreeStyle Libre has a dedicated sensor attached to the back of the upper arm, and when you hold your smartphone or dedicated reader over the sensor, the measured values are displayed on the screen. It can be read through clothing, and one sensor can record 24-hour glucose profiles for up to 14 days. With the FreeStyle LibreLink app, you can quickly and discreetly read sensors with your smartphone. Additionally, people with diabetes can share their glucose data with their doctors via LibreView.
FreeStyle Libre 2 and insurance coverage
When FreeStyle Libre 2 is used with the FreeStyle LibreLink app, glucose values measured every minute will be displayed on your smartphone in real time. It also has selectable alert functions, which contribute to better outcomes such as improving glucose profiles and reducing hypo/hyperglycemia [3], [4]. FreeStyle Libre 2 is covered by insurance in addition to “C150 Blood glucose self-monitoring addition” and “Specified insurance medical materials 158 related technical fees D231-2 subcutaneous continuous glucose measurement (series)” It will be possible for patients to use it during medical treatment. About diabetes
According to the 2019 National Health and Nutrition Survey, the percentage of people who are strongly suspected of having diabetes (preexisting diabetes) and those who cannot deny the possibility of diabetes (prediabetes) is estimated to be 27.3%. Five].
About blood sugar trends
“Glycemic trends” is a concept in diabetes management. Continuous glucose meters (CGMs) and other devices that measure glucose levels continuously 24 hours a day, including during sleep, use an analysis method called AGP (Ambulatory Glucose Profile) to help patients and doctors monitor blood sugar trends (fluctuations). It is now possible to “visualize”. Visualization of blood sugar trends displays blood sugar fluctuations and trends not as points (measured values at a certain point in time) but as waveform lines (continuously measured values), making it easy to see the overall picture and trends of blood sugar management status. You can figure it out. By visualizing blood sugar trends, people with diabetes will be able to quickly notice the presence of unconscious hypoglycemia, nocturnal hypoglycemia, and hyperglycemia, and will be able to predict and take countermeasures. We hope that this will make it easier to take action.
About Abbott
Abbott is a global healthcare leader that helps people live their best lives at every stage of life. Abbott’s breakthrough technologies, including industry-leading diagnostics and devices, medical devices, nutritional products, and branded generic pharmaceutical businesses and products, have a profound impact on people’s lives. It spans. Currently, approximately 114,000 employees work in more than 160 countries around the world. Abbott (https://www.abbott.com), Abbott Japan (https://www.abbott.co.jp), LinkedIn
(https://www.linkedin.com/company/abbott-/), Face Book
(https://www.facebook.com/Abbott), Instagram
(https://www.instagram.com/Abbottglobal), X
(https://twitter.com/AbbottNews), YouTube (https:// Please also refer to YouTube Japan (https://www.youtube.com/@abbottjapan).
――――――――――――――――――――――
[1] 2020 Abbott research
[2] 2023 Abbott research
[3] Roland H. Stimson, et al. : Diabetic Medicine. 2023 ; 00 : e15130. [4] Leelarathna L, et al.: N Engl J Med. 2022;387(16): 1477-1487. [5] 2019 “National Health and Nutrition Survey” (Ministry of Health, Labor and Welfare)
Medical device approval number:
FreeStyle Libre (brand name: FreeStyle Libre, generic name: glucose monitoring system, approval number: 22800BZX00212000), FreeStyle Libre 2 (brand name: FreeStyle Libre 2, generic name: glucose monitoring system, approval number: 30300BZX00119000)
(C) 2024 Abbott. All Rights Reserved. “FreeStyle”, “Libre”, “FreeStyle Libre Sensor” and related brand marks are owned by Abbott.
More details about this release:
https://prtimes.jp/main/html/rd/p/000000029.000034735.html